Influenza Vaccine Effectiveness in Preventing Outpatient, Inpatient, and Severe Cases of Laboratory-Confirmed Influenza
about
The Saudi Thoracic Society guidelines for influenza vaccinationsInfluenza vaccine effectiveness assessment through sentinel virological data in three post-pandemic seasons.Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14.Enhanced Estimates of the Influenza Vaccination Effect in Preventing Mortality: A Prospective Cohort Study.Seasonal Influenza A H1N1pdm09 Virus and Severe Outcomes: A Reason for Broader Vaccination in Non-Elderly, At-Risk People.A cross-sectional analysis of symptom severity in adults with influenza and other acute respiratory illness in the outpatient setting.Influenza vaccination coverage and effectiveness in young children in Thailand, 2011-2013Application of the screening method to monitor influenza vaccine effectiveness among the elderly in GermanyDoes Influenza Vaccination Modify Influenza Severity? Data on Older Adults Hospitalized With Influenza During the 2012-2013 Season in the United States.Influenza vaccine prevents medically attended influenza-associated acute respiratory illness in adults aged ≥50 yearsThe effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012.Vaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease.Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination.Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013A Case of Influenza A (H3N2) Complicated by Community-Acquired Pneumonia and Death in a Young Healthy Adult during the 2013-2014 Season.Enteric fever and its impact on returning travellers.Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014-2015.Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza.Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010-2011.Respiratory syncytial virus hospitalization in middle-aged and older adults.Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies.Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010-2012.High intensive care unit admission rate for 2013-2014 influenza is associated with a low rate of vaccinationInfluenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination.Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern Spain, 2010/11 to 2015/16.Influenza vaccination status and outcomes among influenza-associated hospitalizations in Columbus, Ohio (2012-2015).On the bias of estimates of influenza vaccine effectiveness from test-negative studies.Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study.The Effectiveness of Influenza Vaccination in Different Groups.Markers of prognosis specific to influenza infection: are we there yet?Assessing the benefits of early pandemic influenza vaccine availability: a case study for Ontario, Canada.Recurrence of pericarditis after influenza vaccination: a case report and review of the literature.Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16
P2860
Q28394218-E80F9133-A140-4875-9ADE-A4CE69A6BE7FQ30369475-0DF93058-5D81-4EC1-8F6A-27F5D59C43FCQ30373099-12984B04-E331-4220-A6BA-ADF8C9131AD3Q30377295-B2695409-157C-4E16-B65B-C4BFDCD445FAQ30395111-01595780-0B31-4F2C-8B6B-8AC18C1347C5Q33581365-AEAA8E7C-F673-4730-83E5-EC2309AE05EEQ35158303-661FDCF0-02E7-4C94-9CD0-AE66FF7CA6AFQ35211657-72D02546-BB5C-4464-90C0-38B471010BA7Q35589650-9315C101-0F83-4C92-A021-4847A3A9BECDQ35608431-EE938E4D-0DD0-4073-8579-3696F2072D4AQ36207731-93BBC628-5EF1-4881-A9D9-0BA5EE56178CQ36385284-04248C10-2E52-41BE-A168-7AEDC09DD736Q36396691-EBA71F3B-F021-4D92-8D7E-67613934717BQ36497877-DDE3A92D-B6B4-44E5-86C1-9C8FDD24A324Q37629862-7FC28702-C5ED-4986-85E6-73338F39BD53Q38390741-D11F75F9-356E-4AD5-A6C4-6A7702FAE86DQ38406947-D32ADF96-C5C8-4324-A5B5-85B27920A152Q38774410-1E68E4B8-EB37-45F4-9DC9-A2ED9B0B0F62Q39530697-E634F82B-20BA-4F7C-A88A-54FAF649B5D3Q41931250-0825554E-5A81-4D2F-9073-6451716B0880Q41932605-2589AECB-F297-467E-B91F-DF0E36B2B4E7Q42228543-D8A6A516-EB51-4C8A-B0DD-0C3771A248A0Q42372123-CAC1ED5E-DD31-44D2-9519-41173ABCC354Q47137946-ED5E7D61-511C-410C-947D-CB7FB5572582Q47162930-879B3595-7BDA-41FB-BBAE-3B3239D2C652Q47552950-EB67BD44-8BE9-4F5D-B933-28CB0FB086EDQ47612308-40ADD83A-90AB-4FF0-8993-5C99038B43DEQ47709222-084FDF33-8D0F-4C57-B392-5694B9528457Q49400944-E03B02FE-B9C3-48B8-BB55-3BF08C9286E3Q51298621-D4CACBEF-EF02-47E6-BC29-E64521AA7627Q51846130-7595E3D1-1A56-42B9-B21E-A5C0EB937EB8Q52565452-25B857E8-9DAF-40BE-A423-D76D39C01280Q55261109-93DBF375-845E-458D-9CD5-F589755BC0DAQ58796261-6BFF6B35-E451-42F5-83B0-F86C26D02B39
P2860
Influenza Vaccine Effectiveness in Preventing Outpatient, Inpatient, and Severe Cases of Laboratory-Confirmed Influenza
description
article
@en
im März 2013 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2013
@uk
name
Influenza Vaccine Effectivenes ...... Laboratory-Confirmed Influenza
@en
Influenza Vaccine Effectivenes ...... Laboratory-Confirmed Influenza
@nl
type
label
Influenza Vaccine Effectivenes ...... Laboratory-Confirmed Influenza
@en
Influenza Vaccine Effectivenes ...... Laboratory-Confirmed Influenza
@nl
prefLabel
Influenza Vaccine Effectivenes ...... Laboratory-Confirmed Influenza
@en
Influenza Vaccine Effectivenes ...... Laboratory-Confirmed Influenza
@nl
P2093
P2860
P50
P356
P1476
Influenza vaccine effectivenes ...... laboratory-confirmed influenza
@en
P2093
Ady Castro
Angela Domínguez
CIBERESP Cases and Controls in Influenza Working Group Spain
Jenaro Astray
José María Mayoral
Juan Carlos Galán
Maretva Baricot
Miguel Delgado-Rodríguez
Nuria Soldevila
P2860
P304
P356
10.1093/CID/CIT194
P407
P50
P577
2013-03-26T00:00:00Z